Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients

被引：0
|
作者：
Vered Fuchs
Waleed Kian
Rachel Lichtenberg
Jonah M. Cooper
Areen A. Remilah
Daniel Levin
Nir Peled
Laila C. Roisman
机构：
[1] Ben-Gurion University of the Negev,Goldman Medical School, Faculty of Health Sciences
[2] Shaare Zedek Medical Center,The Oncology Institute
[3] Ben-Gurion University of the Negev,Medical School for International Health
[4] The Institute of Nuclear Medicine and Molecular Imaging,undefined
来源：
Clinical Drug Investigation | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 192
页数：7
相关论文
共 50 条
  • [41] Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
    Ulivi, Paola
    Urbini, Milena
    Petracci, Elisabetta
    Canale, Matteo
    Dubini, Alessandra
    Bartolini, Daniela
    Calistri, Daniele
    Cravero, Paola
    Fonzi, Eugenio
    Martinelli, Giovanni
    Priano, Ilaria
    Andrikou, Kalliopi
    Bronte, Giuseppe
    Crino, Lucio
    Delmonte, Angelo
    CANCERS, 2022, 14 (10)
  • [42] Canadian consensus: a new systemic treatment algorithm for advanced EGFR-mutated non-small-cell lung cancer
    Melosky, B.
    Banerji, S.
    Blais, N.
    Chu, Q.
    Juergens, R.
    Leighl, N. B.
    Liu, G.
    Cheema, P.
    CURRENT ONCOLOGY, 2020, 27 (02) : E146 - E155
  • [43] Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?
    Leonetti, Alessandro
    Facchinetti, Francesco
    Tiseo, Marcello
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [44] Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
    Di Noia, V.
    D'Aveni, A.
    D'Argento, E.
    Rossi, S.
    Ghirardelli, P.
    Bortolotti, L. .
    Vavassori, V.
    Bria, E.
    Ceresoli, G. L.
    ESMO OPEN, 2021, 6 (06)
  • [45] Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA
    Tsuboi, Masahiro
    Weder, Walter
    Escriu, Carles
    Blakely, Collin
    He, Jianxing
    Dacic, Sanja
    Yatabe, Yasushi
    Zeng, Lingmin
    Walding, Andrew
    Chaft, Jamie E.
    FUTURE ONCOLOGY, 2021, 17 (31) : 4045 - 4055
  • [46] MERTK Activation Drives Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Yan, D.
    Huelse, J.
    Parker, R.
    Wang, X.
    Frye, S.
    Earp, H. S.
    Deryckere, D.
    Graham, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1147 - S1147
  • [47] Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
    Kunimasa, Kei
    Kamada, Risa
    Oka, Toru
    Oboshi, Makiko
    Kimura, Madoka
    Inoue, Takako
    Tamiya, Motohiro
    Nishikawa, Tatsuya
    Yasui, Taku
    Shioyama, Wataru
    Nishino, Kazumi
    Imamura, Fumio
    Kumagai, Toru
    Fujita, Masashi
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 1 - 10
  • [48] Factors associated with recurrent leptomeningeal metastases in patients with EGFR-mutated non-small-cell lung cancer
    Watanabe, Hiroko
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (11): : 836 - 838
  • [49] Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer
    Remon, Jordi
    Lacroix, Ludovic
    Jovelet, Cecile
    Caramella, Caroline
    Howarth, Karen
    Plagnol, Vincent
    Rosenfeld, Nitzan
    Morris, Clive
    Mezquita, Laura
    Pannet, Chloe
    Ngocamus, Maud
    Le Pechoux, Cecile
    Adam, Julien
    Grecea, Alina-Miruna
    Planchard, David
    Vassal, Gilles
    Benitez, Jose Carlos
    Gazzah, Anas
    Green, Emma
    Soria, Jean-Charles
    Besse, Benjamin
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 14
  • [50] Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer
    Di Marino, Pietro
    Chiapperino, Cosima
    Primavera, Francesca Chiara
    Martino, Maria Teresa
    Brocco, Davide
    Carella, Consiglia
    Grassadonia, Antonino
    Tinari, Nicola
    De Tursi, Michele
    ONCOTARGETS AND THERAPY, 2022, 15 : 407 - 410
12345